Compounding Pharmacy · Est. 1999 · Atlanta, GA · 503A
Pavilion Compounding Pharmacy Review
Atlanta, Georgia, 1999: that is where and when Pavilion Compounding Pharmacy started as a 503A. PCAB accreditation is held, and per the company website, licenses in 7 states. Compounded prescriptions are the business, among them GLP-1 medications and bioidentical hormone pellets sold as SteriPellets.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
GLP-1 Partners
None of these fill through Pavilion Compounding Pharmacy. They are compounded GLP-1 sellers we have an affiliate relationship with. Each carries the same score it would without one.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Cash-pay pricing · HSA/FSA accepted · every partner checked by our editors
YourEra
Semaglutide at $99/month, well below the typical price
Starting price: $99/mo
Get started →Read review YourEra →Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
Starting price: $59/mo + membership
Get started →Read review Collective →Found
People who want clinician visits billed to commercial insurance, with compounded medication in the plan price
Starting price: $179/mo
Get started →Read review Found →Embody
A flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Starting price: $79/mo
Get started →Read review Embody →| Provider | Starting price | |
|---|---|---|
9.0YourEra | $99/mo | Get started → |
9.1Collective | $59/mo + membership | Get started → |
7.3Found | $179/mo | Get started → |
9.3Embody | $79/mo | Get started → |
Accreditations and Standards
Sterile compounding in this country runs on one rulebook, General Chapter <797> of the United States Pharmacopeia[4]. Depending on what is being made, the finished preparation is then tested for sterility under USP <71>[5] and for bacterial endotoxins under USP <85>[6]. Every pharmacy on this page owes those standards already. Which regulator oversees the pharmacy depends on its route, set out in our explainer on 503A and 503B compounding pharmacies. What follows is what this one has added on top.
What It Compounds
Whether any pharmacy may compound semaglutide or tirzepatide at all turns on where the reference product sits on the FDA Drug Shortage List. When a drug comes off that list the door closes, and it has closed before[7].
States Licensed (7)
What Regulators Have on File
Ratings Elsewhere
How GLP Watchdog Scored This Pharmacy
We research every score ourselves. The methodology page sets out how each part is weighted. To check any pharmacy yourself, follow the six public checks in our guide to verifying an online GLP-1 pharmacy, or run its name through the pharmacy legitimacy lookup.
High confidence · Last verified · How we check provider data
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources & methodology — as of November 2026
- 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
- 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
- 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
- 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.